These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Vidal-Vanaclocha F, Amézaga C, Asumendi A, Kaplanski G, Dinarello CA. Cancer Res; 1994 May 15; 54(10):2667-72. PubMed ID: 8168095 [Abstract] [Full Text] [Related]
5. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity. Kim TH, Jiang HH, Park CW, Youn YS, Lee S, Chen X, Lee KC. J Control Release; 2011 Feb 28; 150(1):63-9. PubMed ID: 21062635 [Abstract] [Full Text] [Related]
6. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth. Benny O, Duvshani-Eshet M, Cargioli T, Bello L, Bikfalvi A, Carroll RS, Machluf M. Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):768-76. PubMed ID: 15701867 [Abstract] [Full Text] [Related]
7. Sustained delivery of endostatin improves the efficacy of therapy in Lewis lung cancer model. Wu J, Ding D, Ren G, Xu X, Yin X, Hu Y. J Control Release; 2009 Mar 04; 134(2):91-7. PubMed ID: 19084038 [Abstract] [Full Text] [Related]
8. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres. He JT, Su HB, Li GP, Tao XM, Mo W, Song HY. Int J Pharm; 2006 Feb 17; 309(1-2):101-8. PubMed ID: 16413979 [Abstract] [Full Text] [Related]
9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination. Wang D, Molavi O, Lutsiak ME, Elamanchili P, Kwon GS, Samuel J. J Pharm Pharm Sci; 2007 Feb 17; 10(2):217-30. PubMed ID: 17706180 [Abstract] [Full Text] [Related]
14. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor. Li SH, Cai SX, Liu B, Ma KW, Wang ZP, Li XK. Acta Pharmacol Sin; 2006 Jun 17; 27(6):754-9. PubMed ID: 16723096 [Abstract] [Full Text] [Related]
15. A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. Bar D, Apte RN, Voronov E, Dinarello CA, Cohen S. FASEB J; 2004 Jan 17; 18(1):161-3. PubMed ID: 14597552 [Abstract] [Full Text] [Related]
16. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Liu J, Meisner D, Kwong E, Wu XY, Johnston MR. Biomaterials; 2007 Jul 17; 28(21):3236-44. PubMed ID: 17434581 [Abstract] [Full Text] [Related]
17. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres. Kim H, Jeong D, Kang HE, Lee KC, Na K. J Pharm Pharmacol; 2013 Jan 17; 65(1):11-21. PubMed ID: 23215683 [Abstract] [Full Text] [Related]
18. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Jaganathan KS, Vyas SP. Vaccine; 2006 May 08; 24(19):4201-11. PubMed ID: 16446012 [Abstract] [Full Text] [Related]
19. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Giordano GG, Refojo MF, Arroyo MH. Invest Ophthalmol Vis Sci; 1993 Aug 08; 34(9):2743-51. PubMed ID: 8344796 [Abstract] [Full Text] [Related]
20. The effect of poly (aspartic acid-co-lactic acid) nanospheres on the lung metastasis of B16BL6 melanoma cells by intravenous administration. Hara K, Tsujimoto H, Huang CC, Kawashima Y, Mimura H, Miwa N. Oncol Rep; 2006 Dec 08; 16(6):1215-20. PubMed ID: 17089040 [Abstract] [Full Text] [Related] Page: [Next] [New Search]